New Rochelle, NY, United States of America

Erica M Gomes-Dagama

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Erica M Gomes-Dagama

Introduction

Erica M Gomes-Dagama is a notable inventor based in New Rochelle, NY, recognized for her significant contributions to cancer research through her innovative patents. With two patents to her name, her work focuses on enhancing cancer treatment methodologies, particularly through the utilization of labeled HSP90 inhibitors.

Latest Patents

Among her latest patents, the first concerns various methods of using labeled HSP90 inhibitors aimed at improving the treatment outcomes for cancer patients. This invention includes both ex vivo and in vivo methods to determine the likelihood of a tumor's response to therapy with these inhibitors. The second patent provides compelling evidence that the abundance of the oncogenic HSP90 species can predict sensitivity to HSP90 inhibition therapy, thereby serving as a crucial biomarker for HSP90 therapy. In this context, 'oncogenic HSP90' refers to a specific form of the chaperone complex that is prevalent in tumor cells and supports the malignant phenotype by regulating the folding of overexpressed and mutated proteins, as well as facilitating complex formation of aberrantly activated signaling molecules.

Career Highlights

Erica has made significant strides in her career by working with renowned institutions such as the Sloan-Kettering Institute for Cancer Research and Cornell University. Her research aims to not only understand the mechanics of cancer better but also to find innovative solutions that can improve patient outcomes in oncology.

Collaborations

Throughout her career, Erica has collaborated with notable researchers such as Gabriela Chiosis and Tony Taldone. These collaborations highlight her commitment to advancing cancer research and her ability to work alongside other experts in the field, fostering a community of innovation.

Conclusion

Erica M Gomes-Dagama exemplifies the spirit of innovation in cancer research. Through her patents and collaborations, she continues to contribute valuable insights and advances in the treatment of cancer, demonstrating the significant impact that a dedicated inventor can have in the medical field. Her work encourages ongoing research and development in the use of targeted therapies, paving the way for future breakthroughs in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…